Sanofi

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

2 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities Just now (07:03 PM IST)

Sanofi Pays Regeneron $1 Billion Upfront to Deepen Drug Alliance and Reignite R&D

Sanofi has agreed to pay Regeneron $1 billion upfront in a broadened collaboration that could be worth as much as $8 billion, extending one of the biopharma sector’s most productive partnerships. The deal gives Sanofi access to four early-stage assets and comes alongside a legal settlement, underscoring both the commercial value of the alliance and the strategic urgency to refresh each company’s pipeline.

By RDU Global Wire6 min read

Markets, IPOs & WealthJust now (07:19 PM IST)

Medico Remedies Among Five Healthcare Stocks to Hit 52-Week Lows as Sensex Slips 242 Points

Indian healthcare counters came under renewed pressure on Thursday, with five BSE Healthcare Index stocks touching fresh 52-week lows as the Sensex fell 242 points to 72,529. Medico Remedies, Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India and Eris Lifesciences all marked their weakest levels in a year, underscoring the depth of the sector’s recent correction. Several of these names have now shed as much as 48% in a month, reflecting sustained selling in defensive pockets of the market.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Sanofi:

Washington, D.C.(1)Regeneron Pharmaceuticals(1)